A Brazilian discovery promises to revolutionize the effectiveness of chemotherapy, drastically reducing the treatment’s side effects.
Researchers at the Federal University of Mato Grosso do Sul have developed an innovative technology capable of reducing tumor growth by up to 99.6% in experimental tests. The system uses microscopic silica nanoparticles as intelligent carriers, capable of delivering chemotherapy drugs directly to tumor cells, minimizing exposure to healthy tissue.
Thanks to this targeted approach, scientists were able to maintain high efficacy against the tumor using significantly lower doses of drugs, with the potential to significantly reduce the side effects of chemotherapy.
The technology is already the subject of patent applications and the research group is now looking for partners to initiate the next phases of clinical trials on humans.